Clinical Trial – Women's Heart Attack Research Program: Platelet Sub-Study (HARP) (HARP) – Heart Attack

1 Answer

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
This prospective observational cohort study, will investigate the platelet phenotype, platelet genetic composition, and role of platelets as effector cells in women with myocardial infarction (MINOCA or MI-CAD) and controls. This study, which will take place at NYU and Bellevue Medical Center, may have concurrent enrollment with the HARP Main Imaging (NCT02914483) and HARP Stress Ancillary Studies (NCT02270359). Additionally, a group of age and race matched disease controls 'CATH-NOCA' composed of women with stable angina referred for cardiac catheterization, will be enrolled. Blood obtained during the initial catheterization, 2 months post-MI, and following the stress study (for those participants enrolled in the stress study) will be utilized for platelet testing.
Study Type  : Observational [Patient Registry]
Estimated Enrollment  : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: Women's Heart Attack Research Program: Platelet Sub-Study (HARP); Platelet Collection for Women With Myocardial Infarction
Study Start Date  : August 2016
Estimated Primary Completion Date  : April 2020
Estimated Study Completion Date  : April 2020
Contacts
Contact: Jeffrey Berger, MD 212 263 4004 [email protected]
Contact: Harmony R Reynolds, MD 646-501-0302 [email protected]
Locations
United States, New York
NYU Langone Medical Center Recruiting
New York, New York, United States, 10016
Contact: Jeffrey Berger, MD
ClinicalTrials.gov Identifier: NCT03022552
...